Dr Matthew S West, MD in Aurora, CO - Medicare Neurology

Dr Matthew S West, MD is a medicare enrolled "Psychiatry & Neurology - Neurology" physician in Aurora, Colorado. He went to University Of Colorado School Of Medicine, Denver and graduated in 2006 and has 18 years of diverse experience with area of expertise as Neurology. He is a member of the group practice University Physicians Incorporated and his current practice location is 12605 E 16th Ave, Aurora, Colorado. You can reach out to his office (for appointments etc.) via phone at (303) 338-4545.

Dr Matthew S West is licensed to practice in Colorado (license number 48836) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1629115985.

Contact Information

	Dr Matthew S West, MD
	12605 E 16th Ave, Aurora, CO 80045-2545
	(303) 338-4545
	Not Available

Physician's Profile

Full Name	Dr Matthew S West
Gender	Male
Speciality	Neurology
Experience	18 Years
Location	12605 E 16th Ave, Aurora, Colorado
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Matthew S West attended and graduated from University Of Colorado School Of Medicine, Denver in 2006

NPI Data:

NPI Number: 1629115985
Provider Enumeration Date: 01/30/2007
Last Update Date: 07/23/2019

Medicare PECOS Information:

PECOS PAC ID: 8022141555
Enrollment ID: I20100804000069

Medical Identifiers

Medical identifiers for Dr Matthew S West such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1629115985	NPI	-	NPPES
026519	Other	CO	KAISER COMMERCIAL NUMBER
26886324	Medicaid	CO

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2084N0400X	Psychiatry & Neurology - Neurology	48836 (Colorado)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
University Of Colorado Hospital Authority	Aurora, CO	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
University Physicians Incorporated	3476465667	2657

News Archive

SDI releases 2011 rating of top 100 integrated healthcare networks

SDI announced today the release of the SDI 2011 Top 100 IHNs, the 14th edition of its annual assessment of the 100 most integrated healthcare networks (IHNs). SDI's report, regarded as the nation's premier rating system, evaluates IHNs on their performance and degree of integration.

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Today, the International Osteoporosis Foundation (IOF) released a new report, revealing approximately 80 percent of patients treated in clinics or hospitals following a fracture are not screened for osteoporosis or risk of future falls. Left untreated, these patients are at high risk of suffering secondary fractures and facing a future of pain, disfigurement, long-term disability and even early death.

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

The lack of a gene called LBP-1a in the mouse embryo prevents normal growth of blood vessels in the placenta. This finding suggests that a similar defect in humans could play a role in fetal growth retardation, infant mortality and spontaneous abortion.

Swecure receives US patent approval for preventive allergy treatment

Swecure, a research and development stage biotechnology company primarily focused on developing novel treatments for immunoregulatory diseases such as allergy, IBD and IBS, receives patent approval grant by the US Patent and Trademark Office. The invention relates to a use of bacterial superantigens for the prevention of allergy in children as well as a method for the prevention of inflammatory disorders.

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. announced today that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for NUCYNTA ER (tapentadol) extended-release tablets, an oral analgesic, for the management of neuropathic pain associated with diabetic peripheral neuropathy in adults.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Matthew S West allows following entities to bill medicare on his behalf.

Entity Name	University Physicians Incorporated
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1962461889 PECOS PAC ID: 3476465667 Enrollment ID: O20031105000375

News Archive

SDI releases 2011 rating of top 100 integrated healthcare networks

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Swecure receives US patent approval for preventive allergy treatment

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Matthew S West is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Matthew S West, MD 1375 E 20th Ave, Denver, CO 80205-5422 Ph: (303) 338-4545	Dr Matthew S West, MD 12605 E 16th Ave, Aurora, CO 80045-2545 Ph: (303) 338-4545

News Archive

SDI releases 2011 rating of top 100 integrated healthcare networks

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Swecure receives US patent approval for preventive allergy treatment

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Psychiatry & Neurology Doctors in Aurora, CO

Lea C Watson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1890 N Revere Ct, Aurora, CO 80045 Phone: 720-848-0000
Robert House, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000
Ann Olincy, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 12605 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000
Paul Moe, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234
Dr. Erin Schwarz, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1537 Alton St, Aurora, CO 80010 Phone: 303-617-2300
Robert Clyman, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-777-1234
Dr. Bishara Bhasi, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 13123 E 16th Ave, Aurora, CO 80045 Phone: 720-848-0000

Dr Matthew S West, MD - Medicare Neurology in Aurora, CO

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

SDI releases 2011 rating of top 100 integrated healthcare networks

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Swecure receives US patent approval for preventive allergy treatment

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Medicare Reassignments

SDI releases 2011 rating of top 100 integrated healthcare networks

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Swecure receives US patent approval for preventive allergy treatment

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

SDI releases 2011 rating of top 100 integrated healthcare networks

IOF report: 80% of patients with fracture are not screened for osteoporosis or risk of future falls

Lack of a gene called LBP-1a in the embryo prevents normal growth of blood vessels in the placenta

Swecure receives US patent approval for preventive allergy treatment

J&JPRD submits NUCYNTA ER sNDA to FDA for DPN associated neuropathic pain

Psychiatry & Neurology Doctors in Aurora, CO